Companies in #Precision Oncology

Enliven Therapeutics is a clinical-stage precision oncology company developing allosteric small-molecule therapies targeting validated oncology pathways, with a focus on menin inhibitors for acute myeloid leukemia (AML) and other genetically defined cancers. Its lead program ELVN-001 is being developed for patients with NPM1-mutant and KMT2A-rearranged leukemias.

SimBioSys is a digital health company applying AI to tumor biology to enable precision oncology. Its platform integrates multi-modal patient data to model tumor behavior and predict response to therapy. Partners with Ferrum Health (2026) to expand AI-powered surgical planning access.